Skip to main content
. Author manuscript; available in PMC: 2008 Jan 16.
Published in final edited form as: Cancer Gene Ther. 2007 Jan 19;14(4):421–430. doi: 10.1038/sj.cgt.7701028

Figure 5.

Figure 5

Supernatant luciferase release from infected SK-OV-3luc spheroids show patterns that reflect differences in viral doses. (a) Higher doses generally led to earlier and higher peaks in luciferase release. (b) When displayed as cumulative values, these data show that because more cells survive longer, lower doses of virus allow a more prolonged luciferase release and apparently greater total luciferase release than higher doses do.